-
Mashup Score: 44Managing common toxicities associated with checkpoint inhibitor and chemotherapy combinations for untreated classic Hodgkin lymphoma - 10 day(s) ago
Managing common toxicities associated with checkpoint inhibitors and chemotherapy in untreated classic Hodgkin lymphoma (Figure generated in Biorender).
Source: onlinelibrary.wiley.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 23Pseudothrombocytopenia due to Phagocytosis of Platelets by Polymorphonuclear Leukocytes - 10 day(s) ago
Click on the article title to read more.
Source: onlinelibrary.wiley.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 113Maintenance strategies for relapse prevention and treatment - 10 day(s) ago
Abstract. Posttransplant relapse is the most significant challenge in allogeneic stem cell transplantation (alloSCT). Posttransplant interventions, in conj
Source: ashpublications.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 55Biology of post-transplant relapse: actionable features - 11 day(s) ago
Abstract. In patients receiving allogeneic hematopoietic cell transplantation to cure acute myeloid leukemia (AML), recurrence of the underlying disease, o
Source: ashpublications.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 108Maintenance strategies for relapse prevention and treatment - 11 day(s) ago
Abstract. Posttransplant relapse is the most significant challenge in allogeneic stem cell transplantation (alloSCT). Posttransplant interventions, in conj
Source: ashpublications.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 195How I treat refractory and relapsed acute myeloid leukemia - 11 day(s) ago
Using a series of 3 illustrative cases, Thol and colleagues discuss their approach to relapsed/refractory acute myeloid leukemia. Although allogeneic hemat
Source: ashpublications.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 25Lower-intensity CPX-351 plus venetoclax induction for adults with newly diagnosed AML unfit for intensive chemotherapy - 13 day(s) ago
Key PointsLower-intensity CPX-351 plus venetoclax was tolerated as induction therapy in adults with poor-risk AML unfit for intense chemotherapy.Combinatio
Source: ashpublications.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 52Mast cell Leukemia - 13 day(s) ago
Shoot for 150-160 chars
Source: imagebank.hematology.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 79Pseudo Auer rods in Splenic marginal zone lymphoma. 1 - 13 day(s) ago
Shoot for 150-160 chars
Source: imagebank.hematology.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 53
Abstract. In contrast to B-cell lymphoma, the advent of modern targeting drugs and immunotherapeutics has not led to major breakthroughs in the treatment o
Source: ashpublications.orgCategories: General Medicine News, Hem/OncsTweet
Managing common toxicities associated with checkpoint inhibitor and chemotherapy combinations for untreated classic Hodgkin lymphoma #lymsm |British Journal of Haematology | Wiley Online Library https://t.co/JdCwOcQUOh https://t.co/DYxGMIZrb6